Infect. Immun., Nov 1997, 4668-4674, Vol 65, No. 11
Copyright © 1997, American Society for Microbiology

Catalase, a novel antigen for Helicobacter pylori vaccination

FJ Radcliff, SL Hazell, T Kolesnikow, C Doidge and A Lee
School of Microbiology and Immunology, The University of New South Wales, Sydney, Australia.

The efficacy of an orogastric vaccine comprised of purified Helicobacter pylori catalase plus the mucosal adjuvant cholera toxin (CT) was examined with both the Helicobacter felis and H. pylori mouse models with BALB/c mice. Native H. pylori catalase (200 microg) plus CT was initially used as a vaccine antigen in the H. felis mouse model and protected 80% (8 of 10) of the challenged animals, while all control animals were infected (20 of 20). In a follow-up experiment, recombinant H. pylori catalase plus CT was used for immunization, and groups of mice were challenged with the Sydney strain of H. pylori. Immunization with recombinant catalase protected a significant proportion (9 of 10) of the mice from H. pylori challenge, indicating that this enzyme should be considered as a candidate for a future vaccine. This study provides the first available data on the efficacy of protective immunization with the new Sydney strain of H. pylori in a mouse model. These data also provide indirect evidence that proteins which are normally intracellular, such as catalase, may be present on the surface of H. pylori and thus may provide targets for immunization.

This article has been cited by other articles:

• Taylor, J. M., Ziman, M. E., Fong, J., Solnick, J. V., Vajdy, M. (2007). Possible Correlates of Long-Term Protection against Helicobacter pylori following Systemic or Combinations of Mucosal and Systemic Immunizations. Infect. Immun. 75: 3462-3469 [Abstract] [Full Text]  
• Alyamani, E. J., Brandt, P., Pena, J. A., Major, A. M., Fox, J. G., Suerbaum, S., Versalovic, J. (2007). Helicobacter hepaticus catalase shares surface-predicted epitopes with mammalian catalases. Microbiology 153: 1006-1016 [Abstract] [Full Text]  
• Wang, G., Conover, R. C., Benoit, S., Olczak, A. A., Olson, J. W., Johnson, M. K., Maier, R. J. (2004). Role of a Bacterial Organic Hydroperoxide Detoxification System in Preventing Catalase Inactivation. J. Biol. Chem. 279: 51908-51914 [Abstract] [Full Text]  
• Garhart, C. A., Nedrud, J. G., Heinzel, F. P., Sigmund, N. E., Czinn, S. J. (2003). Vaccine-Induced Protection against Helicobacter pylori in Mice Lacking Both Antibodies and Interleukin-4. Infect. Immun. 71: 3628-3633 [Abstract] [Full Text]  
• Harris, A. G., Wilson, J. E., Danon, S. J., Dixon, M. F., Donegan, K., Hazell, S. L. (2003). Catalase (KatA) and KatA-associated protein (KapA) are essential to persistent colonization in the Helicobacter pylori SS1 mouse model. Microbiology 149: 665-672 [Abstract] [Full Text]  
• Raghavan, S., Hjulstrom, M., Holmgren, J., Svennerholm, A.-M. (2002). Protection against Experimental Helicobacter pylori Infection after Immunization with Inactivated H. pylori Whole-Cell Vaccines. Infect. Immun. 70: 6383-6388 [Abstract] [Full Text]  
• Sabarth, N., Hurwitz, R., Meyer, T. F., Bumann, D. (2002). Multiparameter Selection of Helicobacter pylori Antigens Identifies Two Novel Antigens with High Protective Efficacy. Infect. Immun. 70: 6499-6503 [Abstract] [Full Text]  
• Sabarth, N., Lamer, S., Zimny-Arndt, U., Jungblut, P. R., Meyer, T. F., Bumann, D. (2002). Identification of Surface Proteins of Helicobacter pylori by Selective Biotinylation, Affinity Purification, and Two-dimensional Gel Electrophoresis. J. Biol. Chem. 277: 27896-27902 [Abstract] [Full Text]  
• Suzuki, N., Wakasugi, M., Nakaya, S., Kokubo, N., Sato, M., Kajiyama, H., Takahashi, R., Hirata, H., Ezure, Y., Fukuda, Y., Shimoyama, T. (2002). Catalase, a Specific Antigen in the Feces of Human Subjects Infected with Helicobacter pylori. CVI 9: 784-788 [Abstract] [Full Text]  
• Garhart, C. A., Redline, R. W., Nedrud, J. G., Czinn, S. J. (2002). Clearance of Helicobacter pylori Infection and Resolution of Postimmunization Gastritis in a Kinetic Study of Prophylactically Immunized Mice. Infect. Immun. 70: 3529-3538 [Abstract] [Full Text]  
• Johnson, C. H., Klotz, M. G., York, J. L., Kruft, V., McEwen, J. E. (2002). Redundancy, phylogeny and differential expression of Histoplasma capsulatum catalases. Microbiology 148: 1129-1142 [Abstract] [Full Text]  
• Rokbi, B., Seguin, D., Guy, B., Mazarin, V., Vidor, E., Mion, F., Cadoz, M., Quentin-Millet, M.-J. (2001). Assessment of Helicobacter pylori Gene Expression within Mouse and Human Gastric Mucosae by Real-Time Reverse Transcriptase PCR. Infect. Immun. 69: 4759-4766 [Abstract] [Full Text]  
• Kotloff, K. L., Sztein, M. B., Wasserman, S. S., Losonsky, G. A., DiLorenzo, S. C., Walker, R. I. (2001). Safety and Immunogenicity of Oral Inactivated Whole-Cell Helicobacter pylori Vaccine with Adjuvant among Volunteers with or without Subclinical Infection. Infect. Immun. 69: 3581-3590 [Abstract] [Full Text]  
• Solnick, J. V., Schauer, D. B. (2001). Emergence of Diverse Helicobacter Species in the Pathogenesis of Gastric and Enterohepatic Diseases. Clin. Microbiol. Rev. 14: 59-97 [Abstract] [Full Text]  
• Keenan, J., Oliaro, J., Domigan, N., Potter, H., Aitken, G., Allardyce, R., Roake, J. (2000). Immune Response to an 18-Kilodalton Outer Membrane Antigen Identifies Lipoprotein 20 as a Helicobacter pylori Vaccine Candidate. Infect. Immun. 68: 3337-3343 [Abstract] [Full Text]  
• RUIZ-BUSTOS, E., SIERRA-BELTRAN, A., ROMERO, M.J., RODRIGUEZ-JARAMILLO, C., ASCENCIO, F. (2000). Protection of BALB/c mice against experimental Helicobacter pylori infection by oral immunisation with H. pylori heparan sulphate-binding proteins coupled to cholera toxin {beta}-subunit. J Med Microbiol 49: 535-541 [Abstract] [Full Text]  
• Solnick, J. V., Canfield, D. R., Hansen, L. M., Torabian, S. Z. (2000). Immunization with Recombinant Helicobacter pylori Urease in Specific-Pathogen-Free Rhesus Monkeys (Macaca mulatta). Infect. Immun. 68: 2560-2565 [Abstract] [Full Text]  
• Kimmel, B., Bosserhoff, A., Frank, R., Gross, R., Goebel, W., Beier, D. (2000). Identification of Immunodominant Antigens from Helicobacter pylori and Evaluation of Their Reactivities with Sera from Patients with Different Gastroduodenal Pathologies. Infect. Immun. 68: 915-920 [Abstract] [Full Text]  
• Hocking, D., Webb, E., Radcliff, F., Rothel, L., Taylor, S., Pinczower, G., Kapouleas, C., Braley, H., Lee, A., Doidge, C. (1999). Isolation of Recombinant Protective Helicobacter pylori Antigens. Infect. Immun. 67: 4713-4719 [Abstract] [Full Text]  
• Marais, A., Mendz, G. L., Hazell, S. L., Megraud, F. (1999). Metabolism and Genetics of Helicobacter pylori: the Genome Era. Microbiol. Mol. Biol. Rev. 63: 642-674 [Abstract] [Full Text]  
• Rossi, G., Rossi, M., Vitali, C. G., Fortuna, D., Burroni, D., Pancotto, L., Capecchi, S., Sozzi, S., Renzoni, G., Braca, G., Del Giudice, G., Rappuoli, R., Ghiara, P., Taccini, E. (1999). A Conventional Beagle Dog Model for Acute and Chronic Infection with Helicobacter pylori. Infect. Immun. 67: 3112-3120 [Abstract] [Full Text]  
• Ermak, T. H., Giannasca, P. J., Nichols, R., Myers, G. A., Nedrud, J., Weltzin, R., Lee, C. K., Kleanthous, H., Monath, T. P. (1998). Immunization of Mice with Urease Vaccine Affords Protection against Helicobacter pylori Infection in the Absence of Antibodies and Is Mediated by MHC Class II-restricted Responses. J. Exp. Med. 188: 2277-2288 [Abstract] [Full Text]  
• CRABTREE, J E (1998). Eradication of chronic Helicobacter pylori infection by therapeutic vaccination. Gut 43: 7-8 [Full Text]